$CVR
CHICAGO RIVET & MACHINE CO

2024 Q2 Form 10-Q Financial Statement

#000119312524136148 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $8.059M $7.853M
YoY Change 0.11% -10.04%
Cost Of Revenue $6.644M $7.109M
YoY Change -20.72% -13.86%
Gross Profit $1.415M $744.6K
YoY Change -530.18% 55.93%
Gross Profit Margin 17.56% 9.48%
Selling, General & Admin $1.308M $1.648M
YoY Change -3.79% 31.02%
% of Gross Profit 92.4% 221.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $322.0K $323.4K
YoY Change 5.2% 5.68%
% of Gross Profit 22.75% 43.44%
Operating Expenses $1.308M $1.648M
YoY Change -3.79% 31.02%
Operating Profit $107.6K -$903.3K
YoY Change -106.37% 15.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $45.96K $28.47K
YoY Change 99.85% -33.88%
Pretax Income $153.5K -$874.8K
YoY Change -109.22% 18.68%
Income Tax $11.37K -$176.8K
% Of Pretax Income 7.41%
Net Earnings $142.1K -$698.0K
YoY Change -110.84% 19.7%
Net Earnings / Revenue 1.76% -8.89%
Basic Earnings Per Share
Diluted Earnings Per Share $0.15 -$0.72
COMMON SHARES
Basic Shares Outstanding 966.1K shares 966.1K shares
Diluted Shares Outstanding 966.1K shares 966.1K shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.627M $2.666M
YoY Change -18.36% -40.21%
Cash & Equivalents $1.886M $1.291M
Short-Term Investments $741.8K $1.375M
Other Short-Term Assets $443.7K $505.0K
YoY Change 5.15% 20.17%
Inventory $6.938M $6.747M
Prepaid Expenses
Receivables $5.393M $5.464M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.48M $15.92M
YoY Change -22.43% -26.73%
LONG-TERM ASSETS
Property, Plant & Equipment $11.36M $11.38M
YoY Change -5.42% -4.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $490.7K $501.8K
YoY Change
Total Long-Term Assets $11.85M $11.88M
YoY Change -1.34% -0.77%
TOTAL ASSETS
Total Short-Term Assets $15.48M $15.92M
Total Long-Term Assets $11.85M $11.88M
Total Assets $27.33M $27.79M
YoY Change -14.51% -17.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $902.2K $1.389M
YoY Change -26.91% -14.36%
Accrued Expenses $309.1K $313.1K
YoY Change 266.9% 170.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.109M $2.620M
YoY Change -13.29% 0.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.109M $2.620M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.109M $2.620M
YoY Change -36.02% -25.15%
SHAREHOLDERS EQUITY
Retained Earnings $27.55M $27.51M
YoY Change -11.13% -15.43%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.922M $3.922M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $25.22M $25.17M
YoY Change
Total Liabilities & Shareholders Equity $27.33M $27.79M
YoY Change -14.51% -17.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $142.1K -$698.0K
YoY Change -110.84% 19.7%
Depreciation, Depletion And Amortization $322.0K $323.4K
YoY Change 5.2% 5.68%
Cash From Operating Activities $363.5K -$398.8K
YoY Change -151.01% -75.85%
INVESTING ACTIVITIES
Capital Expenditures $305.6K $93.09K
YoY Change -11.9% -77.48%
Acquisitions
YoY Change
Other Investing Activities $633.2K $492.5K
YoY Change 19.35% -1.1%
Cash From Investing Activities $327.6K $399.4K
YoY Change 78.35% 372.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -96.62K -$96.61K
YoY Change -54.54% -54.55%
NET CHANGE
Cash From Operating Activities 363.5K -$398.8K
Cash From Investing Activities 327.6K $399.4K
Cash From Financing Activities -96.62K -$96.61K
Net Change In Cash 594.5K -$95.94K
YoY Change -180.17% -94.61%
FREE CASH FLOW
Cash From Operating Activities $363.5K -$398.8K
Capital Expenditures $305.6K $93.09K
Free Cash Flow $57.97K -$491.8K
YoY Change -105.47% -76.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Entity File Number
EntityFileNumber
000-01227
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IL
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-0904920
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
901 Frontenac Road
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Naperville
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60563
CY2024Q1 dei City Area Code
CityAreaCode
630
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
357-8500
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
CVR
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
966132 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1291132 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1387075 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
1374956 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1771120 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5463717 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4275882 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
118301 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
6746675 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7327653 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
534224 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
580287 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
504958 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
380562 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
15915662 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
15840880 usd
CY2024Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
1510513 usd
CY2023Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
1510513 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6835619 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6835619 usd
CY2024Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
37724746 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
37952902 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46070878 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46299034 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34695580 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34633952 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11375298 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11665082 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
501773 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
324943 usd
CY2024Q1 us-gaap Assets
Assets
27792733 usd
CY2023Q4 us-gaap Assets
Assets
27830905 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1388599 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
788974 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
634373 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
514900 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
313112 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
129963 usd
CY2024Q1 us-gaap Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
284377 usd
CY2023Q4 us-gaap Customer Advances And Deposits Current
CustomerAdvancesAndDepositsCurrent
430179 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2620461 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1864016 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2620461 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1864016 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1138096 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1138096 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
966132 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
966132 shares
CY2024Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1138096 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1138096 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447134 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447134 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27509140 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28303757 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
3922098 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3922098 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
25172272 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25966889 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27792733 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27830905 usd
CY2024Q1 us-gaap Revenues
Revenues
7853181 usd
CY2023Q1 us-gaap Revenues
Revenues
8729725 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
7108619 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
8252222 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
744562 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
477503 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1647865 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1257695 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-903303 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-780192 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28469 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43055 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-874834 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-737137 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-176830 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-154000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-698004 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-583137 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.72
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.6
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.72
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.6
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966132 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966132 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25966889 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-698004 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2024Q1 us-gaap Dividends
Dividends
96613 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
25172272 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
30986798 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-583137 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2023Q1 us-gaap Dividends
Dividends
212549 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30191112 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-698004 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-583137 usd
CY2024Q1 us-gaap Depreciation
Depreciation
323405 usd
CY2023Q1 us-gaap Depreciation
Depreciation
306032 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-36886 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-176830 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-43000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1187835 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1197937 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
118301 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
580978 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-877722 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-78333 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-160452 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
599625 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
924168 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
119473 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
212746 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
183149 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-212227 usd
CY2024Q1 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-145802 usd
CY2023Q1 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-19881 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-398759 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1651410 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
93085 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
413419 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
96350 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1133641 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
498000 usd
CY2024Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
737477 usd
CY2023Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
399429 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
84581 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
96613 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
212549 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-96613 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-212549 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-95943 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1779378 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1387075 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4045101 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1291132 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2265723 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Arial;margin:0">2.  The Company extends credit on the basis of terms that are customary within our markets to various companies doing business primarily in the automotive industry.  The Company has a concentration of credit risk primarily within the automotive industry and in the Midwestern United States.  The Company has established an allowance for accounts that may become uncollectible in the future.  This estimated allowance is based primarily on management's evaluation of the financial condition of the customer and historical experience.  The Company monitors its accounts receivable and charges to expense an amount equal to its estimate of potential credit losses.  The Company considers a number of factors in determining its estimates, including the length of time its trade accounts receivable are past due, the Company's previous loss history and the customer's current ability to pay its obligation.  The Company also considers current economic conditions, the economic outlook and industry-specific factors in its evaluation.  Accounts receivable balances are charged off against the allowance when it is determined that the receivable will not be recovered.</p>
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7853181 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8729725 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7853181 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8729725 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2432691 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2878869 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2463760 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2374795 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2390224 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2614989 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
7286675 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
7868653 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
540000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
541000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
6746675 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7327653 usd

Files In Submission

Name View Source Status
cvr-20240331_cal.xml Edgar Link unprocessable
0001193125-24-136148-index-headers.html Edgar Link pending
0001193125-24-136148-index.html Edgar Link pending
0001193125-24-136148.txt Edgar Link pending
0001193125-24-136148-xbrl.zip Edgar Link pending
cvr-20240331.xsd Edgar Link pending
d805117d10q.htm Edgar Link pending
d805117dex311.htm Edgar Link pending
d805117dex312.htm Edgar Link pending
d805117dex321.htm Edgar Link pending
d805117dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cvr-20240331_def.xml Edgar Link unprocessable
cvr-20240331_lab.xml Edgar Link unprocessable
cvr-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d805117d10q_htm.xml Edgar Link completed